Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$19.97 - $24.43 $3.61 Million - $4.41 Million
-180,645 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$23.49 - $30.56 $946,106 - $1.23 Million
-40,277 Reduced 18.23%
180,645 $4.3 Million
Q4 2020

Feb 02, 2021

SELL
$16.78 - $27.3 $150,365 - $244,635
-8,961 Reduced 3.9%
220,922 $5.78 Million
Q3 2020

Nov 05, 2020

BUY
$12.46 - $19.98 $186,139 - $298,481
14,939 Added 6.95%
229,883 $4 Million
Q2 2020

Aug 12, 2020

BUY
$11.0 - $18.26 $19,228 - $31,918
1,748 Added 0.82%
214,944 $3.62 Million
Q1 2020

May 12, 2020

SELL
$10.11 - $14.04 $1.64 Million - $2.28 Million
-162,375 Reduced 43.23%
213,196 $2.54 Million
Q4 2019

Jan 27, 2020

BUY
$12.06 - $16.96 $2.08 Million - $2.93 Million
172,830 Added 85.25%
375,571 $4.54 Million
Q3 2019

Oct 31, 2019

BUY
$10.41 - $14.66 $829,718 - $1.17 Million
79,704 Added 64.78%
202,741 $2.87 Million
Q2 2019

Aug 15, 2019

SELL
$9.78 - $12.76 $7,823 - $10,208
-800 Reduced 0.65%
123,037 $1.37 Million
Q1 2019

May 03, 2019

SELL
$10.03 - $15.71 $98,875 - $154,869
-9,858 Reduced 7.37%
123,837 $1.45 Million
Q4 2018

Feb 08, 2019

SELL
$11.29 - $17.19 $183,044 - $278,701
-16,213 Reduced 10.82%
133,695 $1.79 Million
Q3 2018

Nov 13, 2018

SELL
$12.27 - $15.65 $86,503 - $110,332
-7,050 Reduced 4.49%
149,908 $2.1 Million
Q2 2018

Aug 15, 2018

BUY
$15.3 - $19.69 $237,777 - $306,002
15,541 Added 10.99%
156,958 $2.47 Million
Q1 2018

May 11, 2018

SELL
$14.59 - $25.5 $337,612 - $590,070
-23,140 Reduced 14.06%
141,417 $2.33 Million
Q4 2017

Feb 06, 2018

BUY
$15.77 - $20.72 $33,085 - $43,470
2,098 Added 1.29%
164,557 $2.97 Million
Q3 2017

Nov 15, 2017

BUY
$12.3 - $19.3 $2 Million - $3.14 Million
162,459
162,459 $3.14 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.3B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.